Business Description
Lukas Biomedical Inc
ISIN : TW0006814007
Share Class Description:
ROCO:6814: Ordinary SharesDescription
Lukas Biomedical Inc is engaged in the research and development of immunotherapy for cancer treatment technologies. It researches on the Memory T cell (LuLym-T) to improve the clinical outcome of cancer treatment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | -29.31 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.94 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.7 | |||||
| 3-Year EPS without NRI Growth Rate | -61.9 | |||||
| 3-Year FCF Growth Rate | -25.8 | |||||
| 3-Year Book Growth Rate | -0.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.36 | |||||
| 9-Day RSI | 54.46 | |||||
| 14-Day RSI | 53.64 | |||||
| 6-1 Month Momentum % | 17.42 | |||||
| 12-1 Month Momentum % | -17.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.53 | |||||
| Days Inventory | 159.18 | |||||
| Days Sales Outstanding | 17.24 | |||||
| Days Payable | 28.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 5.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.96 | |||||
| Operating Margin % | -16.71 | |||||
| Net Margin % | -17.96 | |||||
| FCF Margin % | -2.75 | |||||
| ROE % | -11.52 | |||||
| ROA % | -7.9 | |||||
| ROIC % | -8.5 | |||||
| ROC (Joel Greenblatt) % | -34.86 | |||||
| ROCE % | -8.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.97 | |||||
| PB Ratio | 3.37 | |||||
| Price-to-Tangible-Book | 3.57 | |||||
| EV-to-EBIT | -34.39 | |||||
| EV-to-EBITDA | -303.7 | |||||
| EV-to-Revenue | 5.67 | |||||
| EV-to-FCF | -195.56 | |||||
| Earnings Yield (Greenblatt) % | -2.91 | |||||
| FCF Yield % | -0.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lukas Biomedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 211.844 | ||
| EPS (TTM) (NT$) | -1.027 | ||
| Beta | 0.84 | ||
| Volatility % | 22.17 | ||
| 14-Day RSI | 53.64 | ||
| 14-Day ATR (NT$) | 1.284428 | ||
| 20-Day SMA (NT$) | 30.104727 | ||
| 12-1 Month Momentum % | -17.11 | ||
| 52-Week Range (NT$) | 22.359922 - 39.502529 | ||
| Shares Outstanding (Mil) | 37.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lukas Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lukas Biomedical Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lukas Biomedical Inc Frequently Asked Questions
What is Lukas Biomedical Inc(ROCO:6814)'s stock price today?
The current price of ROCO:6814 is NT$30.10. The 52 week high of ROCO:6814 is NT$39.50 and 52 week low is NT$22.36.
When is next earnings date of Lukas Biomedical Inc(ROCO:6814)?
The next earnings date of Lukas Biomedical Inc(ROCO:6814) is .
Does Lukas Biomedical Inc(ROCO:6814) pay dividends? If so, how much?
Lukas Biomedical Inc(ROCO:6814) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers